padova study: prasinezumab in patients with early parkinson's disease
Published 1 year ago • 471 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
1:34
padova trial: prasinezumab in early parkinson's disease
-
1:44
exploratory delayed-start analysis of pasadena in early-stage parkinson's disease
-
1:24
pasadena trial: prasinezumab in early parkinson's disease
-
0:55
open label extension of prasinezumab in parkinson's disease: 1 year updates
-
1:57
update on the pasadena trial of prasinezumab for parkinson's disease
-
13:48
a post-hoc analysis of the prasinezumab trial in early parkinson's disease
-
1:29
prasinezumab: an anti-alpha-synuclein antibody in parkinson's disease
-
1:38
assessing the efficacy of antibodies targeting α-synuclein
-
2:03
what is the future of immunotherapy in parkinson’s disease?
-
2:12
key clinical trials of disease modifying therapies in parkinson's disease
-
3:56
ikt-148009 as a potential disease-modifying therapy in parkinson's disease
-
2:43
update on parkinson’s disease clinical trials
-
3:21
developments in parkinson’s disease research and pasadena clinical trial update
-
1:49
learnings from the pasadena trial in parkinson's disease
-
2:21
what have clinical trials taught us about parkinson's disease?
-
4:43
the patient experience in cell- and gene-therapy trials for parkinson’s disease
-
2:05
cinpanemab in early parkinson's disease | nejm
-
2:22
enrolling treatment-naive patients in parkinson’s disease clinical trials
-
1:52
learnings from clinical trial failure in parkinson's disease